Pharmala Biotech Holdings Inc. (CSE:MDMA)

Pharmala Biotech Holdings Revenue

Pharmala Biotech Holdings had revenue of 206.44K CAD in the quarter ending November 30, 2025, with 260.30% growth. This brings the company's revenue in the last twelve months to 754.64K, up 121.87% year-over-year. In the fiscal year ending August 31, 2025, Pharmala Biotech Holdings had annual revenue of 605.50K, down -41.51%.

• Revenue (ttm): 754.64K
• Revenue Growth: +121.87%
• P/S Ratio: 14.44
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 10.89M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Aug 31, 2025	605.50K	-429.80K	-41.51%
Aug 31, 2024	1.04M	503.29K	94.60%
Aug 31, 2023	532.00K	453.93K	581.44%
Aug 31, 2022	78.07K	-	-
Aug 31, 2021	-	-	-